Multicenter, randomized, double-blind, phase III trial to investigate the efficacy and safety of oral BIBF 1120 plus standard pemetrexed therapy compared to placebo plus standard pemetrexed therapy in patients with stage IIIB/IV or recurrent non small cell lung cancer after failure of first line chemotherapy


Grant Data
Project Title
Multicenter, randomized, double-blind, phase III trial to investigate the efficacy and safety of oral BIBF 1120 plus standard pemetrexed therapy compared to placebo plus standard pemetrexed therapy in patients with stage IIIB/IV or recurrent non small cell lung cancer after failure of first line chemotherapy
Principal Investigator
Dr Ho, James Chung Man   (Principal investigator)
Co-Investigator(s)
Dr Lam Jamie Chung Mei   (Co-Investigator)
Dr Wang Julie Kwan Ling   (Co-Investigator)
Dr Lam David Chi Leung   (Co-Investigator)
Dr Wong Matthew King Yan   (Co-Investigator)
Duration
45
Start Date
2009-04-01
Completion Date
2012-12-31
Amount
328733
Conference Title
Presentation Title
Keywords
Stage IIIB/V or recurrent NSCLC
Discipline
Respiration,Cancer
Panel
Medicine
Grant Type
Pharmaceutical Industry - General Award
Funding Year
2008/2009
Status
On-going